Accession Number: | 0001104659-21-078786 |
Date: | 2021-06-07 |
Issuer: | ARMATA PHARMACEUTICALS, INC. (ARMP) |
Original Submission Date: |
KRAMER ROBIN
C/O ARMATA PHARMACEUTICALS, INC.
4503 GLENCOE AVENUE
MARINA DEL REY, CA 90292
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 4.29 | 2021-06-07 | deemed execution date | A | 28,000 (a) | 2031-06-07 | common stock 28,000 | $4.29 | 28,000 | direct |
ID | footnote |
---|---|
f1 | the stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant. |